NO301241B1 - Prövecelle, apparat og fremgangsmåte for bestemmelse av konsentrasjonen av en forbindelse i en vandig væskepröve - Google Patents

Prövecelle, apparat og fremgangsmåte for bestemmelse av konsentrasjonen av en forbindelse i en vandig væskepröve Download PDF

Info

Publication number: NO301241B1
Authority: NO; Norway
Prior art keywords: electrode; cell; sample; reaction; opening
Prior art date: 1988-03-15

Application number

NO904001A

Other languages

English (en)

Norwegian (no)

Other versions

NO904001D0 (no

NO904001L (no

Inventor

Paul A Pottgen

Neil J Szuminsky

Jonathan L Talbott

Joseph Jordan

Original Assignee

Life Chek Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-03-15

Filing date

1990-09-13

Publication date

1997-09-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26863966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO301241(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-09-13 Application filed by Life Chek Lab filed Critical Life Chek Lab

1990-09-13 Publication of NO904001D0 publication Critical patent/NO904001D0/no

1990-11-06 Publication of NO904001L publication Critical patent/NO904001L/no

1997-09-29 Publication of NO301241B1 publication Critical patent/NO301241B1/no

Links

238000000034 method Methods 0.000 title claims abstract description 46
150000001875 compounds Chemical class 0.000 title claims abstract description 21
238000012360 testing method Methods 0.000 title claims description 35
239000007788 liquid Substances 0.000 title claims description 22
210000001124 body fluid Anatomy 0.000 claims abstract description 7
239000010839 body fluid Substances 0.000 claims abstract description 7
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 71
239000003153 chemical reaction reagent Substances 0.000 claims description 45
238000006243 chemical reaction Methods 0.000 claims description 41
235000012000 cholesterol Nutrition 0.000 claims description 35
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 34
239000008103 glucose Substances 0.000 claims description 34
239000007800 oxidant agent Substances 0.000 claims description 33
210000004369 blood Anatomy 0.000 claims description 22
239000008280 blood Substances 0.000 claims description 22
102000004190 Enzymes Human genes 0.000 claims description 21
108090000790 Enzymes Proteins 0.000 claims description 21
229940088598 enzyme Drugs 0.000 claims description 21
238000005259 measurement Methods 0.000 claims description 20
239000000758 substrate Substances 0.000 claims description 19
AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 18
YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 claims description 18
239000000872 buffer Substances 0.000 claims description 13
-1 TEIS Substances 0.000 claims description 10
238000006555 catalytic reaction Methods 0.000 claims description 10
239000007983 Tris buffer Substances 0.000 claims description 9
239000000203 mixture Substances 0.000 claims description 8
SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 claims description 6
239000011230 binding agent Substances 0.000 claims description 6
238000011534 incubation Methods 0.000 claims description 6
230000008569 process Effects 0.000 claims description 6
108010015776 Glucose oxidase Proteins 0.000 claims description 5
229910019142 PO4 Inorganic materials 0.000 claims description 5
239000000463 material Substances 0.000 claims description 5
239000010452 phosphate Substances 0.000 claims description 5
239000004366 Glucose oxidase Substances 0.000 claims description 4
JAWGVVJVYSANRY-UHFFFAOYSA-N cobalt(3+) Chemical compound [Co+3] JAWGVVJVYSANRY-UHFFFAOYSA-N 0.000 claims description 4
229940116332 glucose oxidase Drugs 0.000 claims description 4
235000019420 glucose oxidase Nutrition 0.000 claims description 4
239000011159 matrix material Substances 0.000 claims description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 3
239000007991 ACES buffer Substances 0.000 claims description 3
239000008001 CAPS buffer Substances 0.000 claims description 3
239000007995 HEPES buffer Substances 0.000 claims description 3
239000007987 MES buffer Substances 0.000 claims description 3
239000007993 MOPS buffer Substances 0.000 claims description 3
FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 claims description 3
DBXNUXBLKRLWFA-UHFFFAOYSA-N N-(2-acetamido)-2-aminoethanesulfonic acid Chemical compound NC(=O)CNCCS(O)(=O)=O DBXNUXBLKRLWFA-UHFFFAOYSA-N 0.000 claims description 3
UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 claims description 3
239000007997 Tricine buffer Substances 0.000 claims description 3
208000034953 Twin anemia-polycythemia sequence Diseases 0.000 claims description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
239000007998 bicine buffer Substances 0.000 claims description 3
KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 claims description 3
229910052751 metal Inorganic materials 0.000 claims description 3
239000002184 metal Substances 0.000 claims description 3
DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims description 2
239000003416 antiarrhythmic agent Substances 0.000 claims description 2
239000003054 catalyst Substances 0.000 claims description 2
229940088597 hormone Drugs 0.000 claims description 2
239000005556 hormone Substances 0.000 claims description 2
229940126585 therapeutic drug Drugs 0.000 claims description 2
230000000007 visual effect Effects 0.000 claims description 2
229910017052 cobalt Inorganic materials 0.000 claims 2
239000010941 cobalt Substances 0.000 claims 2
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims 2
230000000977 initiatory effect Effects 0.000 claims 2
230000003288 anthiarrhythmic effect Effects 0.000 claims 1
230000003556 anti-epileptic effect Effects 0.000 claims 1
239000001961 anticonvulsive agent Substances 0.000 claims 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 1
239000010970 precious metal Substances 0.000 claims 1
230000011664 signaling Effects 0.000 claims 1
239000012491 analyte Substances 0.000 abstract description 8
238000004458 analytical method Methods 0.000 abstract description 3
239000010410 layer Substances 0.000 description 40
108010089254 Cholesterol oxidase Proteins 0.000 description 21
238000007254 oxidation reaction Methods 0.000 description 20
QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 18
230000003647 oxidation Effects 0.000 description 16
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 10
239000000370 acceptor Substances 0.000 description 10
239000004094 surface-active agent Substances 0.000 description 9
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 7
RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 7
241000187654 Nocardia Species 0.000 description 7
239000000174 gluconic acid Substances 0.000 description 7
235000012208 gluconic acid Nutrition 0.000 description 7
239000012528 membrane Substances 0.000 description 7
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
238000004082 amperometric method Methods 0.000 description 6
229920003023 plastic Polymers 0.000 description 6
239000004033 plastic Substances 0.000 description 6
230000001105 regulatory effect Effects 0.000 description 6
230000027756 respiratory electron transport chain Effects 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
239000000126 substance Substances 0.000 description 6
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
GUQQBLRVXOUDTN-XOHPMCGNSA-N 3-[dimethyl-[3-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 GUQQBLRVXOUDTN-XOHPMCGNSA-N 0.000 description 5
108010010803 Gelatin Proteins 0.000 description 5
108010055297 Sterol Esterase Proteins 0.000 description 5
102000000019 Sterol Esterase Human genes 0.000 description 5
241000187747 Streptomyces Species 0.000 description 5
229940058573 b-d glucose Drugs 0.000 description 5
230000008901 benefit Effects 0.000 description 5
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 5
230000000694 effects Effects 0.000 description 5
230000002255 enzymatic effect Effects 0.000 description 5
239000012530 fluid Substances 0.000 description 5
238000009472 formulation Methods 0.000 description 5
229920000159 gelatin Polymers 0.000 description 5
239000008273 gelatin Substances 0.000 description 5
235000019322 gelatine Nutrition 0.000 description 5
235000011852 gelatine desserts Nutrition 0.000 description 5
238000012544 monitoring process Methods 0.000 description 5
239000001103 potassium chloride Substances 0.000 description 5
235000011164 potassium chloride Nutrition 0.000 description 5
238000011002 quantification Methods 0.000 description 5
239000000243 solution Substances 0.000 description 5
241000186146 Brevibacterium Species 0.000 description 4
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
229910021607 Silver chloride Inorganic materials 0.000 description 4
YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 4
229960003964 deoxycholic acid Drugs 0.000 description 4
229910001882 dioxygen Inorganic materials 0.000 description 4
238000006056 electrooxidation reaction Methods 0.000 description 4
238000005516 engineering process Methods 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
239000008363 phosphate buffer Substances 0.000 description 4
238000005070 sampling Methods 0.000 description 4
229910052709 silver Inorganic materials 0.000 description 4
239000004332 silver Substances 0.000 description 4
NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 4
230000007480 spreading Effects 0.000 description 4
238000003892 spreading Methods 0.000 description 4
239000013504 Triton X-100 Substances 0.000 description 3
229920004890 Triton X-100 Polymers 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
230000003197 catalytic effect Effects 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
239000003599 detergent Substances 0.000 description 3
206010012601 diabetes mellitus Diseases 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
239000012811 non-conductive material Substances 0.000 description 3
239000004745 nonwoven fabric Substances 0.000 description 3
239000001301 oxygen Substances 0.000 description 3
229910052760 oxygen Inorganic materials 0.000 description 3
239000011148 porous material Substances 0.000 description 3
230000009467 reduction Effects 0.000 description 3
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 3
229940045946 sodium taurodeoxycholate Drugs 0.000 description 3
YXHRQQJFKOHLAP-FVCKGWAHSA-M sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 YXHRQQJFKOHLAP-FVCKGWAHSA-M 0.000 description 3
UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
108090000371 Esterases Proteins 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
239000004367 Lipase Substances 0.000 description 2
108090001060 Lipase Proteins 0.000 description 2
102000004882 Lipase Human genes 0.000 description 2
102000004895 Lipoproteins Human genes 0.000 description 2
108090001030 Lipoproteins Proteins 0.000 description 2
229930192627 Naphthoquinone Natural products 0.000 description 2
241000222480 Schizophyllum Species 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
238000013019 agitation Methods 0.000 description 2
PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
150000004056 anthraquinones Chemical class 0.000 description 2
230000008859 change Effects 0.000 description 2
239000003638 chemical reducing agent Substances 0.000 description 2
GTKRFUAGOKINCA-UHFFFAOYSA-M chlorosilver;silver Chemical compound [Ag].[Ag]Cl GTKRFUAGOKINCA-UHFFFAOYSA-M 0.000 description 2
238000000970 chrono-amperometry Methods 0.000 description 2
238000004737 colorimetric analysis Methods 0.000 description 2
238000000151 deposition Methods 0.000 description 2
238000013461 design Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
238000002848 electrochemical method Methods 0.000 description 2
239000007772 electrode material Substances 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
239000010408 film Substances 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
238000010030 laminating Methods 0.000 description 2
238000003475 lamination Methods 0.000 description 2
235000019421 lipase Nutrition 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
239000000693 micelle Substances 0.000 description 2
150000002791 naphthoquinones Chemical class 0.000 description 2
229910000510 noble metal Inorganic materials 0.000 description 2
230000001590 oxidative effect Effects 0.000 description 2
229910052763 palladium Inorganic materials 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
239000000047 product Substances 0.000 description 2
229910001923 silver oxide Inorganic materials 0.000 description 2
238000010998 test method Methods 0.000 description 2
239000011800 void material Substances 0.000 description 2
WOAHJDHKFWSLKE-UHFFFAOYSA-N 1,2-benzoquinone Chemical compound O=C1C=CC=CC1=O WOAHJDHKFWSLKE-UHFFFAOYSA-N 0.000 description 1
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
CJVYYDCBKKKIPD-UHFFFAOYSA-N 1-n,1-n,2-n,2-n-tetramethylbenzene-1,2-diamine Chemical compound CN(C)C1=CC=CC=C1N(C)C CJVYYDCBKKKIPD-UHFFFAOYSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
WOGWYSWDBYCVDY-UHFFFAOYSA-N 2-chlorocyclohexa-2,5-diene-1,4-dione Chemical compound ClC1=CC(=O)C=CC1=O WOGWYSWDBYCVDY-UHFFFAOYSA-N 0.000 description 1
IGRSQEOIAAGSGS-UHFFFAOYSA-N 2-ethylcyclohexa-2,5-diene-1,4-dione Chemical compound CCC1=CC(=O)C=CC1=O IGRSQEOIAAGSGS-UHFFFAOYSA-N 0.000 description 1
VTWDKFNVVLAELH-UHFFFAOYSA-N 2-methylcyclohexa-2,5-diene-1,4-dione Chemical compound CC1=CC(=O)C=CC1=O VTWDKFNVVLAELH-UHFFFAOYSA-N 0.000 description 1
QOIXLGYJPBDQSK-UHFFFAOYSA-N 3,6-dioxocyclohexa-1,4-diene-1-sulfonic acid Chemical compound OS(=O)(=O)C1=CC(=O)C=CC1=O QOIXLGYJPBDQSK-UHFFFAOYSA-N 0.000 description 1
YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
VDJKJPMLWJWQIH-UHFFFAOYSA-M 5-ethylphenazin-5-ium;ethyl sulfate Chemical compound CCOS([O-])(=O)=O.C1=CC=C2[N+](CC)=C(C=CC=C3)C3=NC2=C1 VDJKJPMLWJWQIH-UHFFFAOYSA-M 0.000 description 1
RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
108091006149 Electron carriers Proteins 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
239000004642 Polyimide Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
229920000297 Rayon Polymers 0.000 description 1
PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
239000012790 adhesive layer Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000007605 air drying Methods 0.000 description 1
239000012080 ambient air Substances 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
229940097217 cardiac glycoside Drugs 0.000 description 1
239000002368 cardiac glycoside Substances 0.000 description 1
239000000679 carrageenan Substances 0.000 description 1
235000010418 carrageenan Nutrition 0.000 description 1
229920001525 carrageenan Polymers 0.000 description 1
229940113118 carrageenan Drugs 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
150000001840 cholesterol esters Chemical class 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
239000008199 coating composition Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000002131 composite material Substances 0.000 description 1
YQNUXCCHFKYTJR-BTVCFUMJSA-N cyclohexa-2,5-diene-1,4-dione;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound O=C1C=CC(=O)C=C1.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O YQNUXCCHFKYTJR-BTVCFUMJSA-N 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
229940009976 deoxycholate Drugs 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
235000018823 dietary intake Nutrition 0.000 description 1
229960005156 digoxin Drugs 0.000 description 1
LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000016097 disease of metabolism Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
229960000878 docusate sodium Drugs 0.000 description 1
239000000975 dye Substances 0.000 description 1
238000000840 electrochemical analysis Methods 0.000 description 1
230000005518 electrochemistry Effects 0.000 description 1
238000005868 electrolysis reaction Methods 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000004744 fabric Substances 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
201000010235 heart cancer Diseases 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
208000024348 heart neoplasm Diseases 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
230000002218 hypoglycaemic effect Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
239000011810 insulating material Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
229960004194 lidocaine Drugs 0.000 description 1
239000012035 limiting reagent Substances 0.000 description 1
159000000003 magnesium salts Chemical class 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
229960002695 phenobarbital Drugs 0.000 description 1
150000004986 phenylenediamines Chemical class 0.000 description 1
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
229920001721 polyimide Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
235000019422 polyvinyl alcohol Nutrition 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
BDJXVNRFAQSMAA-UHFFFAOYSA-N quinhydrone Chemical compound OC1=CC=C(O)C=C1.O=C1C=CC(=O)C=C1 BDJXVNRFAQSMAA-UHFFFAOYSA-N 0.000 description 1
239000002964 rayon Substances 0.000 description 1
239000012429 reaction media Substances 0.000 description 1
238000005546 reactive sputtering Methods 0.000 description 1
238000001055 reflectance spectroscopy Methods 0.000 description 1
238000010405 reoxidation reaction Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229940083542 sodium Drugs 0.000 description 1
APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
229930002534 steroid glycoside Natural products 0.000 description 1
150000008143 steroidal glycosides Chemical class 0.000 description 1
AWDRATDZQPNJFN-VAYUFCLWSA-N taurodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 AWDRATDZQPNJFN-VAYUFCLWSA-N 0.000 description 1
239000010409 thin film Substances 0.000 description 1
238000007740 vapor deposition Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000002759 woven fabric Substances 0.000 description 1
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/004—Enzyme electrodes mediator-assisted

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Analysing Materials By The Use Of Radiation (AREA)
Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Measurement Of Resistance Or Impedance (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Paper (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Testing Of Short-Circuits, Discontinuities, Leakage, Or Incorrect Line Connections (AREA)
Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
Radar Systems Or Details Thereof (AREA)

NO904001A 1988-03-15 1990-09-13 Prövecelle, apparat og fremgangsmåte for bestemmelse av konsentrasjonen av en forbindelse i en vandig væskepröve NO301241B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US16829588A	1988-03-15	1988-03-15
US07/322,598 US5128015A (en)	1988-03-15	1989-03-13	Method and apparatus for amperometric diagnostic analysis
PCT/US1989/001057 WO1989008713A1 (en)	1988-03-15	1989-03-14	Method and apparatus for amperometric diagnostic analysis

Publications (3)

Publication Number	Publication Date
NO904001D0 NO904001D0 (no)	1990-09-13
NO904001L NO904001L (no)	1990-11-06
NO301241B1 true NO301241B1 (no)	1997-09-29

Family

ID=26863966

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO904001A NO301241B1 (no)	1988-03-15	1990-09-13	Prövecelle, apparat og fremgangsmåte for bestemmelse av konsentrasjonen av en forbindelse i en vandig væskepröve

Country Status (9)

Country	Link
US (1)	US5128015A (de)
EP (1)	EP0406304B1 (de)
KR (1)	KR900700620A (de)
AT (1)	ATE157123T1 (de)
DE (1)	DE68928266T2 (de)
DK (1)	DK221090A (de)
FI (1)	FI101021B (de)
NO (1)	NO301241B1 (de)
WO (1)	WO1989008713A1 (de)

Families Citing this family (246)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4999582A (en) *	1989-12-15	1991-03-12	Boehringer Mannheim Corp.	Biosensor electrode excitation circuit
AU634863B2 (en) *	1989-12-15	1993-03-04	Roche Diagnostics Operations Inc.	Redox mediator reagent and biosensor
US5508171A (en) *	1989-12-15	1996-04-16	Boehringer Mannheim Corporation	Assay method with enzyme electrode system
US5243516A (en) *	1989-12-15	1993-09-07	Boehringer Mannheim Corporation	Biosensing instrument and method
US5593852A (en)	1993-12-02	1997-01-14	Heller; Adam	Subcutaneous glucose electrode
DE4223791C1 (de) *	1992-07-15	1993-11-18	Eppendorf Geraetebau Netheler	Verfahren und Vorrichtung zum Nachweis von Analyten in Flüssigkeiten
FR2705150B1 (fr) *	1993-05-10	1995-07-21	Asulab Sa	Capteur électrochimique à zones multiples sur disque et son application au dosage du glucose.
AUPM506894A0 (en) *	1994-04-14	1994-05-05	Memtec Limited	Novel electrochemical cells
US5644501A (en) *	1994-12-06	1997-07-01	Lin; Shengfu	Method of using a computer to collect chemical signals directly
US5832410A (en) *	1994-12-06	1998-11-03	Lin; Shengfu	Method of using a computer to collect chemical signals directly
US6153069A (en) *	1995-02-09	2000-11-28	Tall Oak Ventures	Apparatus for amperometric Diagnostic analysis
AUPN239395A0 (en) *	1995-04-12	1995-05-11	Memtec Limited	Method of defining an electrode area
AUPN363995A0 (en)	1995-06-19	1995-07-13	Memtec Limited	Electrochemical cell
US6413410B1 (en)	1996-06-19	2002-07-02	Lifescan, Inc.	Electrochemical cell
US6863801B2 (en) *	1995-11-16	2005-03-08	Lifescan, Inc.	Electrochemical cell
US6638415B1 (en) *	1995-11-16	2003-10-28	Lifescan, Inc.	Antioxidant sensor
US6521110B1 (en)	1995-11-16	2003-02-18	Lifescan, Inc.	Electrochemical cell
AUPN661995A0 (en) *	1995-11-16	1995-12-07	Memtec America Corporation	Electrochemical cell 2
US5989917A (en) *	1996-02-13	1999-11-23	Selfcare, Inc.	Glucose monitor and test strip containers for use in same
US5708247A (en) *	1996-02-14	1998-01-13	Selfcare, Inc.	Disposable glucose test strips, and methods and compositions for making same
US6241862B1 (en)	1996-02-14	2001-06-05	Inverness Medical Technology, Inc.	Disposable test strips with integrated reagent/blood separation layer
US7112265B1 (en)	1996-02-14	2006-09-26	Lifescan Scotland Limited	Disposable test strips with integrated reagent/blood separation layer
US6214612B1 (en)	1996-03-07	2001-04-10	Matsushita Electric Industrial Co., Ltd.	Cholesterol sensor containing electrodes, cholesterol dehydrogenase, nicotinamide adenine dinucleotide and oxidized electron mediator
US6063259A (en) *	1996-06-11	2000-05-16	New Mexico State University Technology Transfer Corporation	Microfabricated thick-film electrochemical sensor for nucleic acid determination
US6632349B1 (en)	1996-11-15	2003-10-14	Lifescan, Inc.	Hemoglobin sensor
JP3394262B2 (ja)	1997-02-06	2003-04-07	セラセンス、インク．	小体積インビトロ被検体センサー
AUPO581397A0 (en) *	1997-03-21	1997-04-17	Memtec America Corporation	Sensor connection means
AUPO585797A0 (en)	1997-03-25	1997-04-24	Memtec America Corporation	Improved electrochemical cell
AUPO855897A0 (en)	1997-08-13	1997-09-04	Usf Filtration And Separations Group Inc.	Automatic analysing apparatus II
US6193865B1 (en)	1997-09-11	2001-02-27	Usf Filtration And Separations Group, Inc.	Analytic cell
US6071391A (en)	1997-09-12	2000-06-06	Nok Corporation	Enzyme electrode structure
US6036924A (en)	1997-12-04	2000-03-14	Hewlett-Packard Company	Cassette of lancet cartridges for sampling blood
US5997817A (en)	1997-12-05	1999-12-07	Roche Diagnostics Corporation	Electrochemical biosensor test strip
US7407811B2 (en)	1997-12-22	2008-08-05	Roche Diagnostics Operations, Inc.	System and method for analyte measurement using AC excitation
US8071384B2 (en)	1997-12-22	2011-12-06	Roche Diagnostics Operations, Inc.	Control and calibration solutions and methods for their use
US7390667B2 (en)	1997-12-22	2008-06-24	Roche Diagnostics Operations, Inc.	System and method for analyte measurement using AC phase angle measurements
EP2085779B1 (de)	1997-12-22	2017-11-01	Roche Diagnostics Operations, Inc.	Messgerät
US7494816B2 (en)	1997-12-22	2009-02-24	Roche Diagnostic Operations, Inc.	System and method for determining a temperature during analyte measurement
US6134461A (en)	1998-03-04	2000-10-17	E. Heller & Company	Electrochemical analyte
US6103033A (en)	1998-03-04	2000-08-15	Therasense, Inc.	Process for producing an electrochemical biosensor
US6878251B2 (en) *	1998-03-12	2005-04-12	Lifescan, Inc.	Heated electrochemical cell
US6475360B1 (en)	1998-03-12	2002-11-05	Lifescan, Inc.	Heated electrochemical cell
US6652734B1 (en)	1999-03-16	2003-11-25	Lifescan, Inc.	Sensor with improved shelf life
US6391005B1 (en)	1998-03-30	2002-05-21	Agilent Technologies, Inc.	Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8480580B2 (en)	1998-04-30	2013-07-09	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8974386B2 (en)	1998-04-30	2015-03-10	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8346337B2 (en)	1998-04-30	2013-01-01	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US6175752B1 (en)	1998-04-30	2001-01-16	Therasense, Inc.	Analyte monitoring device and methods of use
US8465425B2 (en)	1998-04-30	2013-06-18	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US9066695B2 (en)	1998-04-30	2015-06-30	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8688188B2 (en)	1998-04-30	2014-04-01	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US6591125B1 (en)	2000-06-27	2003-07-08	Therasense, Inc.	Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6338790B1 (en)	1998-10-08	2002-01-15	Therasense, Inc.	Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
DE19856885C2 (de)	1998-12-10	2001-03-15	Robert Bischoff	Meßsonde und Verfahren zur Messung der Konzentration von Agenzien in Gasen und/oder Flüssigkeiten
EP1192269A2 (de)	1999-06-18	2002-04-03	Therasense, Inc.	Stofftransportliitierrter in vivo sensor
US7276146B2 (en)	2001-11-16	2007-10-02	Roche Diagnostics Operations, Inc.	Electrodes, methods, apparatuses comprising micro-electrode arrays
US6616819B1 (en)	1999-11-04	2003-09-09	Therasense, Inc.	Small volume in vitro analyte sensor and methods
US6562210B1 (en)	1999-12-30	2003-05-13	Roche Diagnostics Corporation	Cell for electrochemical anaylsis of a sample
US6571651B1 (en) *	2000-03-27	2003-06-03	Lifescan, Inc.	Method of preventing short sampling of a capillary or wicking fill device
US6612111B1 (en) *	2000-03-27	2003-09-02	Lifescan, Inc.	Method and device for sampling and analyzing interstitial fluid and whole blood samples
CA2404262C (en) *	2000-03-29	2009-03-24	University Of Virginia Patent Foundation	Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
US6858433B1 (en)	2000-04-03	2005-02-22	Roche Diagnostics Operations, Inc.	Biosensor electromagnetic noise cancellation
RU2278612C2 (ru) *	2000-07-14	2006-06-27	Лайфскен, Инк.	Иммуносенсор
US6444115B1 (en) *	2000-07-14	2002-09-03	Lifescan, Inc.	Electrochemical method for measuring chemical reaction rates
US8641644B2 (en)	2000-11-21	2014-02-04	Sanofi-Aventis Deutschland Gmbh	Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US6560471B1 (en)	2001-01-02	2003-05-06	Therasense, Inc.	Analyte monitoring device and methods of use
US6576102B1 (en)	2001-03-23	2003-06-10	Virotek, L.L.C.	Electrochemical sensor and method thereof
US6572745B2 (en) *	2001-03-23	2003-06-03	Virotek, L.L.C.	Electrochemical sensor and method thereof
US7981056B2 (en)	2002-04-19	2011-07-19	Pelikan Technologies, Inc.	Methods and apparatus for lancet actuation
AU2002315180A1 (en)	2001-06-12	2002-12-23	Pelikan Technologies, Inc.	Electric lancet actuator
US9226699B2 (en)	2002-04-19	2016-01-05	Sanofi-Aventis Deutschland Gmbh	Body fluid sampling module with a continuous compression tissue interface surface
EP1404235A4 (de)	2001-06-12	2008-08-20	Pelikan Technologies Inc	Verfahren und gerät für eine auf einer blutentnahmekartusche integrierte lanzettenvorrichtung
DE60234598D1 (de)	2001-06-12	2010-01-14	Pelikan Technologies Inc	Selbstoptimierende lanzettenvorrichtung mit adaptationsmittel für zeitliche schwankungen von hauteigenschaften
AU2002320094A1 (en)	2001-06-12	2002-12-23	Pelikan Technologies, Inc.	Integrated blood sampling analysis system with multi-use sampling module
DE60239132D1 (de)	2001-06-12	2011-03-24	Pelikan Technologies Inc	Gerät zur erhöhung der erfolgsrate im hinblick auf die durch einen fingerstich erhaltene blutausbeute
WO2002100252A2 (en)	2001-06-12	2002-12-19	Pelikan Technologies, Inc.	Blood sampling apparatus and method
US8337419B2 (en)	2002-04-19	2012-12-25	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
US7025774B2 (en)	2001-06-12	2006-04-11	Pelikan Technologies, Inc.	Tissue penetration device
US9795747B2 (en)	2010-06-02	2017-10-24	Sanofi-Aventis Deutschland Gmbh	Methods and apparatus for lancet actuation
US9427532B2 (en)	2001-06-12	2016-08-30	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
US20030055360A1 (en) *	2001-09-05	2003-03-20	Zeleznik Matthew A.	Minimally invasive sensing system for measuring rigidity of anatomical matter
CN1702456A (zh)	2001-10-10	2005-11-30	生命扫描有限公司	电化学电池
US7344894B2 (en)	2001-10-16	2008-03-18	Agilent Technologies, Inc.	Thermal regulation of fluidic samples within a diagnostic cartridge
US7018843B2 (en)	2001-11-07	2006-03-28	Roche Diagnostics Operations, Inc.	Instrument
US6997343B2 (en)	2001-11-14	2006-02-14	Hypoguard Limited	Sensor dispensing device
US20030111357A1 (en) *	2001-12-13	2003-06-19	Black Murdo M.	Test meter calibration
US8010174B2 (en)	2003-08-22	2011-08-30	Dexcom, Inc.	Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en)	2003-07-25	2012-09-04	Dexcom, Inc.	Systems and methods for replacing signal data artifacts in a glucose sensor data stream
CA2419213C (en) *	2002-03-07	2011-06-21	Bayer Healthcare Llc	Improved electrical sensor
US20030169426A1 (en) *	2002-03-08	2003-09-11	Peterson Timothy A.	Test member orientation
US20060134713A1 (en)	2002-03-21	2006-06-22	Lifescan, Inc.	Biosensor apparatus and methods of use
US20030180814A1 (en) *	2002-03-21	2003-09-25	Alastair Hodges	Direct immunosensor assay
US7892185B2 (en)	2002-04-19	2011-02-22	Pelikan Technologies, Inc.	Method and apparatus for body fluid sampling and analyte sensing
US7141058B2 (en)	2002-04-19	2006-11-28	Pelikan Technologies, Inc.	Method and apparatus for a body fluid sampling device using illumination
US8579831B2 (en)	2002-04-19	2013-11-12	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US7901362B2 (en)	2002-04-19	2011-03-08	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7229458B2 (en)	2002-04-19	2007-06-12	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7717863B2 (en)	2002-04-19	2010-05-18	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US8784335B2 (en)	2002-04-19	2014-07-22	Sanofi-Aventis Deutschland Gmbh	Body fluid sampling device with a capacitive sensor
US7648468B2 (en)	2002-04-19	2010-01-19	Pelikon Technologies, Inc.	Method and apparatus for penetrating tissue
US7491178B2 (en) *	2002-04-19	2009-02-17	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7244265B2 (en)	2002-04-19	2007-07-17	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7582099B2 (en)	2002-04-19	2009-09-01	Pelikan Technologies, Inc	Method and apparatus for penetrating tissue
US8267870B2 (en)	2002-04-19	2012-09-18	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for body fluid sampling with hybrid actuation
US9248267B2 (en)	2002-04-19	2016-02-02	Sanofi-Aventis Deustchland Gmbh	Tissue penetration device
US7674232B2 (en)	2002-04-19	2010-03-09	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7909778B2 (en)	2002-04-19	2011-03-22	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7892183B2 (en)	2002-04-19	2011-02-22	Pelikan Technologies, Inc.	Method and apparatus for body fluid sampling and analyte sensing
US7198606B2 (en)	2002-04-19	2007-04-03	Pelikan Technologies, Inc.	Method and apparatus for a multi-use body fluid sampling device with analyte sensing
US9795334B2 (en)	2002-04-19	2017-10-24	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US7524293B2 (en)	2002-04-19	2009-04-28	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7175642B2 (en)	2002-04-19	2007-02-13	Pelikan Technologies, Inc.	Methods and apparatus for lancet actuation
US8221334B2 (en)	2002-04-19	2012-07-17	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US7291117B2 (en)	2002-04-19	2007-11-06	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7976476B2 (en)	2002-04-19	2011-07-12	Pelikan Technologies, Inc.	Device and method for variable speed lancet
US7563232B2 (en)	2002-04-19	2009-07-21	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7410468B2 (en)	2002-04-19	2008-08-12	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7371247B2 (en)	2002-04-19	2008-05-13	Pelikan Technologies, Inc	Method and apparatus for penetrating tissue
US7297122B2 (en)	2002-04-19	2007-11-20	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7258693B2 (en)	2002-04-19	2007-08-21	Pelikan Technologies, Inc.	Device and method for variable speed lancet
US7485128B2 (en)	2002-04-19	2009-02-03	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US8360992B2 (en)	2002-04-19	2013-01-29	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US8702624B2 (en)	2006-09-29	2014-04-22	Sanofi-Aventis Deutschland Gmbh	Analyte measurement device with a single shot actuator
US7374544B2 (en)	2002-04-19	2008-05-20	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US9314194B2 (en)	2002-04-19	2016-04-19	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
US7547287B2 (en)	2002-04-19	2009-06-16	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7232451B2 (en)	2002-04-19	2007-06-19	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7331931B2 (en)	2002-04-19	2008-02-19	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US6946299B2 (en) *	2002-04-25	2005-09-20	Home Diagnostics, Inc.	Systems and methods for blood glucose sensing
US20080112852A1 (en) *	2002-04-25	2008-05-15	Neel Gary T	Test Strips and System for Measuring Analyte Levels in a Fluid Sample
US6964871B2 (en) *	2002-04-25	2005-11-15	Home Diagnostics, Inc.	Systems and methods for blood glucose sensing
US6743635B2 (en) *	2002-04-25	2004-06-01	Home Diagnostics, Inc.	System and methods for blood glucose sensing
US7250095B2 (en) *	2002-07-11	2007-07-31	Hypoguard Limited	Enzyme electrodes and method of manufacture
AU2003259741B2 (en) *	2002-08-13	2008-10-23	University Of Virginia Patent Foundation	Managing and processing self-monitoring blood glucose
US7670853B2 (en) *	2002-11-05	2010-03-02	Abbott Diabetes Care Inc.	Assay device, system and method
US7381184B2 (en)	2002-11-05	2008-06-03	Abbott Diabetes Care Inc.	Sensor inserter assembly
US7572237B2 (en)	2002-11-06	2009-08-11	Abbott Diabetes Care Inc.	Automatic biological analyte testing meter with integrated lancing device and methods of use
US8574895B2 (en)	2002-12-30	2013-11-05	Sanofi-Aventis Deutschland Gmbh	Method and apparatus using optical techniques to measure analyte levels
US7811231B2 (en)	2002-12-31	2010-10-12	Abbott Diabetes Care Inc.	Continuous glucose monitoring system and methods of use
US7264139B2 (en) *	2003-01-14	2007-09-04	Hypoguard Limited	Sensor dispensing device
DE602004028463D1 (de)	2003-05-30	2010-09-16	Pelikan Technologies Inc	Verfahren und vorrichtung zur injektion von flüssigkeit
WO2004107964A2 (en)	2003-06-06	2004-12-16	Pelikan Technologies, Inc.	Blood harvesting device with electronic control
US8066639B2 (en)	2003-06-10	2011-11-29	Abbott Diabetes Care Inc.	Glucose measuring device for use in personal area network
WO2006001797A1 (en)	2004-06-14	2006-01-05	Pelikan Technologies, Inc.	Low pain penetrating
US7604592B2 (en)	2003-06-13	2009-10-20	Pelikan Technologies, Inc.	Method and apparatus for a point of care device
US7604721B2 (en)	2003-06-20	2009-10-20	Roche Diagnostics Operations, Inc.	System and method for coding information on a biosensor test strip
US8206565B2 (en)	2003-06-20	2012-06-26	Roche Diagnostics Operation, Inc.	System and method for coding information on a biosensor test strip
US7452457B2 (en)	2003-06-20	2008-11-18	Roche Diagnostics Operations, Inc.	System and method for analyte measurement using dose sufficiency electrodes
US7645421B2 (en)	2003-06-20	2010-01-12	Roche Diagnostics Operations, Inc.	System and method for coding information on a biosensor test strip
US7645373B2 (en)	2003-06-20	2010-01-12	Roche Diagnostic Operations, Inc.	System and method for coding information on a biosensor test strip
US7597793B2 (en)	2003-06-20	2009-10-06	Roche Operations Ltd.	System and method for analyte measurement employing maximum dosing time delay
US7488601B2 (en)	2003-06-20	2009-02-10	Roche Diagnostic Operations, Inc.	System and method for determining an abused sensor during analyte measurement
US7718439B2 (en)	2003-06-20	2010-05-18	Roche Diagnostics Operations, Inc.	System and method for coding information on a biosensor test strip
US8148164B2 (en)	2003-06-20	2012-04-03	Roche Diagnostics Operations, Inc.	System and method for determining the concentration of an analyte in a sample fluid
US8058077B2 (en)	2003-06-20	2011-11-15	Roche Diagnostics Operations, Inc.	Method for coding information on a biosensor test strip
JP4916309B2 (ja)	2003-06-20	2012-04-11	エフホフマン−ラロッシュアクチェンゲゼルシャフト	バイオセンサー試験ストリップ上の、コード情報のためのシステムおよび方法
US20050074828A1 (en) *	2003-07-16	2005-04-07	Dimagno Theodore John	Uae of lipase for high-density lipoprotein cholesterol detection
US20140121989A1 (en)	2003-08-22	2014-05-01	Dexcom, Inc.	Systems and methods for processing analyte sensor data
US8282576B2 (en)	2003-09-29	2012-10-09	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for an improved sample capture device
EP1680014A4 (de)	2003-10-14	2009-01-21	Pelikan Technologies Inc	Verfahren und gerät für eine variable anwenderschnittstelle
US8007656B2 (en)	2003-10-24	2011-08-30	Bayer Healthcare Llc	Enzymatic electrochemical biosensor
USD902408S1 (en)	2003-11-05	2020-11-17	Abbott Diabetes Care Inc.	Analyte sensor control unit
US20050121826A1 (en) *	2003-12-03	2005-06-09	Kiamars Hajizadeh	Multi-sensor device for motorized meter and methods thereof
US7822454B1 (en)	2005-01-03	2010-10-26	Pelikan Technologies, Inc.	Fluid sampling device with improved analyte detecting member configuration
EP1706026B1 (de)	2003-12-31	2017-03-01	Sanofi-Aventis Deutschland GmbH	Verfahren und vorrichtung zur verbesserung der fluidströmung und der probennahme
US20050150763A1 (en) *	2004-01-09	2005-07-14	Butters Colin W.	Biosensor and method of manufacture
BRPI0507376A (pt)	2004-02-06	2007-07-10	Bayer Healthcare Llc	espécie oxidável como uma referência interna para biossensores e método de uso
WO2005089103A2 (en)	2004-02-17	2005-09-29	Therasense, Inc.	Method and system for providing data communication in continuous glucose monitoring and management system
WO2006011062A2 (en)	2004-05-20	2006-02-02	Albatros Technologies Gmbh & Co. Kg	Printable hydrogel for biosensors
US9775553B2 (en)	2004-06-03	2017-10-03	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for a fluid sampling device
WO2005120365A1 (en)	2004-06-03	2005-12-22	Pelikan Technologies, Inc.	Method and apparatus for a fluid sampling device
US7601299B2 (en)	2004-06-18	2009-10-13	Roche Diagnostics Operations, Inc.	System and method for coding information on a biosensor test strip
US7569126B2 (en)	2004-06-18	2009-08-04	Roche Diagnostics Operations, Inc.	System and method for quality assurance of a biosensor test strip
US7556723B2 (en)	2004-06-18	2009-07-07	Roche Diagnostics Operations, Inc.	Electrode design for biosensor
US9788771B2 (en)	2006-10-23	2017-10-17	Abbott Diabetes Care Inc.	Variable speed sensor insertion devices and methods of use
US8652831B2 (en)	2004-12-30	2014-02-18	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for analyte measurement test time
GB0509919D0 (en) *	2005-05-16	2005-06-22	Ralph Ellerker 1795 Ltd	Improvements to door closure system
JP5385607B2 (ja)	2005-07-20	2014-01-08	バイエル・ヘルスケア・エルエルシー	ゲート化電流測定器
KR20130100022A (ko)	2005-09-30	2013-09-06	바이엘 헬스케어 엘엘씨	게이트형 전압 전류 측정 분석물 결정 방법
US7766829B2 (en)	2005-11-04	2010-08-03	Abbott Diabetes Care Inc.	Method and system for providing basal profile modification in analyte monitoring and management systems
US8529751B2 (en)	2006-03-31	2013-09-10	Lifescan, Inc.	Systems and methods for discriminating control solution from a physiological sample
US7620438B2 (en)	2006-03-31	2009-11-17	Abbott Diabetes Care Inc.	Method and system for powering an electronic device
US8226891B2 (en)	2006-03-31	2012-07-24	Abbott Diabetes Care Inc.	Analyte monitoring devices and methods therefor
US20100012049A1 (en) *	2006-04-12	2010-01-21	Jms Co., Ltd	Cavitation heating system and method
US8398443B2 (en) *	2006-04-21	2013-03-19	Roche Diagnostics Operations, Inc.	Biological testing system and connector therefor
US7993512B2 (en)	2006-07-11	2011-08-09	Bayer Healthcare, Llc	Electrochemical test sensor
ES2748685T3 (es)	2006-09-22	2020-03-17	Ascensia Diabetes Care Holdings Ag	Sistema de biosensor que tiene estabilidad y rendimiento de hematocrito potenciados
BRPI0717620A2 (pt)	2006-10-24	2013-10-22	Bayer Healthcare Llc	Amperometria de decaimento transitório
US8732188B2 (en)	2007-02-18	2014-05-20	Abbott Diabetes Care Inc.	Method and system for providing contextual based medication dosage determination
US8930203B2 (en)	2007-02-18	2015-01-06	Abbott Diabetes Care Inc.	Multi-function analyte test device and methods therefor
US8123686B2 (en)	2007-03-01	2012-02-28	Abbott Diabetes Care Inc.	Method and apparatus for providing rolling data in communication systems
US8665091B2 (en)	2007-05-08	2014-03-04	Abbott Diabetes Care Inc.	Method and device for determining elapsed sensor life
US7928850B2 (en)	2007-05-08	2011-04-19	Abbott Diabetes Care Inc.	Analyte monitoring system and methods
US8456301B2 (en)	2007-05-08	2013-06-04	Abbott Diabetes Care Inc.	Analyte monitoring system and methods
US8461985B2 (en)	2007-05-08	2013-06-11	Abbott Diabetes Care Inc.	Analyte monitoring system and methods
US8778168B2 (en)	2007-09-28	2014-07-15	Lifescan, Inc.	Systems and methods of discriminating control solution from a physiological sample
JP5856371B2 (ja)	2007-12-10	2016-02-09	バイエル・ヘルスケア・エルエルシーＢａｙｅｒＨｅａｌｔｈＣａｒｅＬＬＣ	分析対象物を検出するための試薬及び方法
WO2009076271A2 (en) *	2007-12-10	2009-06-18	Bayer Healthcare Llc	Wear-resistant electrochemical test sensor and method of forming the same
US8603768B2 (en)	2008-01-17	2013-12-10	Lifescan, Inc.	System and method for measuring an analyte in a sample
WO2009126900A1 (en)	2008-04-11	2009-10-15	Pelikan Technologies, Inc.	Method and apparatus for analyte detecting device
US8551320B2 (en)	2008-06-09	2013-10-08	Lifescan, Inc.	System and method for measuring an analyte in a sample
US8103456B2 (en)	2009-01-29	2012-01-24	Abbott Diabetes Care Inc.	Method and device for early signal attenuation detection using blood glucose measurements
US9375169B2 (en)	2009-01-30	2016-06-28	Sanofi-Aventis Deutschland Gmbh	Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US20100198034A1 (en)	2009-02-03	2010-08-05	Abbott Diabetes Care Inc.	Compact On-Body Physiological Monitoring Devices and Methods Thereof
US20100213057A1 (en)	2009-02-26	2010-08-26	Benjamin Feldman	Self-Powered Analyte Sensor
US8608937B2 (en)	2009-03-30	2013-12-17	Roche Diagnostics Operations, Inc.	Biosensor with predetermined dose response curve and method of manufacturing
US9226701B2 (en)	2009-04-28	2016-01-05	Abbott Diabetes Care Inc.	Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en)	2009-05-29	2010-12-02	Abbott Diabetes Care Inc.	Medical device antenna systems having external antenna configurations
EP2473098A4 (de)	2009-08-31	2014-04-09	Abbott Diabetes Care Inc	Analytsignalverarbeitungsvorrichtung und -verfahren
US8993331B2 (en)	2009-08-31	2015-03-31	Abbott Diabetes Care Inc.	Analyte monitoring system and methods for managing power and noise
US9320461B2 (en)	2009-09-29	2016-04-26	Abbott Diabetes Care Inc.	Method and apparatus for providing notification function in analyte monitoring systems
US20110168575A1 (en)	2010-01-08	2011-07-14	Roche Diaagnostics Operations, Inc.	Sample characterization based on ac measurement methods
DK3622883T3 (da)	2010-03-24	2021-07-19	Abbott Diabetes Care Inc	Indførerer til medicinsk indretning og fremgangsmåder til at indføre og anvende medicinske indretninger
US8965476B2 (en)	2010-04-16	2015-02-24	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
WO2012084152A1 (en)	2010-12-20	2012-06-28	Roche Diagnostics Gmbh	Controlled slew rate transition for electrochemical analysis
EP3901624B1 (de)	2010-12-22	2024-01-31	Roche Diabetes Care GmbH	Verfahren zur kompensation von fehlerquellen während elektrochemischer tests
EP3677182B1 (de)	2011-11-07	2022-05-04	Abbott Diabetes Care Inc.	Analytüberwachungsvorrichtung und -verfahren
FI3300658T3 (fi)	2011-12-11	2024-03-01	Abbott Diabetes Care Inc	Analyyttianturimenetelmiä
RU2489710C1 (ru) *	2012-02-20	2013-08-10	Владимир Вадимович Мошкин	Способ коммутационной хроноамперометрии
CN106170555B (zh)	2012-09-06	2019-10-22	霍夫曼-拉罗奇有限公司	改进的基质稳定性组合物和方法
US9968306B2 (en)	2012-09-17	2018-05-15	Abbott Diabetes Care Inc.	Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
JP6397822B2 (ja)	2012-10-17	2018-09-26	ユニバーシティオブメリーランド，オフィスオブテクノロジーコマーシャライゼーション	デバイスおよびアミノアシドパシーの検出のためにデバイスを用いる方法
JP6352954B2 (ja)	2013-03-15	2018-07-04	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	電気化学的な分析物測定において回復パルスからの情報を使用する方法およびデバイス、装置とそれらを組み込むシステム
KR101743382B1 (ko)	2013-03-15	2017-06-02	에프. 호프만-라 로슈 아게	전기화학적 측정 중 높은 항산화제 레벨들을 검출하고 그로부터 분석물질 농도를 페일세이프하는 방법들 뿐만 아니라 상기 방법들을 통합한 기기들, 장치들 및 시스템들
WO2014140170A1 (en)	2013-03-15	2014-09-18	Roche Diagnostics Gmbh	Methods of scaling data used to construct biosensor algorithms as well as devices, apparatuses and systems incorporating the same
PL2972268T3 (pl)	2013-03-15	2017-10-31	Hoffmann La Roche	Sposoby zabezpieczenia przed błędem w elektrochemicznym pomiarze analitu, przyrządy i urządzenia oraz układy je zawierające
US9523653B2 (en)	2013-05-09	2016-12-20	Changsha Sinocare Inc.	Disposable test sensor with improved sampling entrance
EP3032250B1 (de)	2013-08-07	2023-10-11	ARKRAY, Inc.	Verfahren zum messen eines stoffes und messvorrichtung mit elektrochemischem biosensor
DK3540429T3 (da)	2013-08-30	2021-02-15	Univ Maryland	Indretning og fremgangsmåder til anvendelse af indretning til detektion af hyperammoniæmi
US9518951B2 (en)	2013-12-06	2016-12-13	Changsha Sinocare Inc.	Disposable test sensor with improved sampling entrance
US9897566B2 (en)	2014-01-13	2018-02-20	Changsha Sinocare Inc.	Disposable test sensor
US9939401B2 (en)	2014-02-20	2018-04-10	Changsha Sinocare Inc.	Test sensor with multiple sampling routes
WO2015161301A1 (en)	2014-04-17	2015-10-22	University Of Maryland, College Park	Device and methods of using device for detection of aminoacidopathies
KR102007585B1 (ko)	2014-11-03	2019-08-05	에프. 호프만-라 로슈 아게	전기화학 테스트 엘리먼트들에 대한 전극 배열들 및 그의 이용 방법들
AU2016255825B2 (en)	2015-04-27	2022-06-30	Children's National Medical Center	Device and methods of using device for detection of hyperammonemia
AU2016260547B2 (en)	2015-05-14	2020-09-03	Abbott Diabetes Care Inc.	Compact medical device inserters and related systems and methods
JP6817111B2 (ja)	2016-03-16	2021-01-20	アークレイ株式会社	電気化学式バイオセンサを用いた物質の測定方法及び測定装置
KR102372113B1 (ko)	2016-10-05	2022-03-07	에프. 호프만-라 로슈 아게	다중 분석물 진단 테스트 엘리먼트들을 위한 검출 시약들 및 전극 배열들, 그리고 그것을 사용하는 방법들
EP3529612B1 (de)	2016-10-24	2024-12-11	F. Hoffmann-La Roche AG	Verfahren zur korrektur der unkompensierten widerstände in den leitenden elementen von biosensoren sowie vorrichtungen und systeme
CA3050721A1 (en)	2017-01-23	2018-07-26	Abbott Diabetes Care Inc.	Systems, devices and methods for analyte sensor insertion
CN108469460B (zh) *	2018-03-09	2019-03-29	深圳市刷新智能电子有限公司	汗液传感器及其制备方法
CN113195022A (zh)	2018-12-21	2021-07-30	雅培糖尿病护理公司	用于分析物传感器插入的系统、装置和方法
CA3188510A1 (en)	2020-08-31	2022-03-03	Vivek S. RAO	Systems, devices, and methods for analyte sensor insertion
US12569168B2 (en)	2020-09-15	2026-03-10	Abbott Diabetes Care Inc.	Systems, devices, and methods for analyte monitoring
WO2023110190A1 (en)	2021-12-13	2023-06-22	Heraeus Medical Gmbh	Tests and methods for detecting bacterial infection
EP4357778A1 (de)	2022-10-20	2024-04-24	Heraeus Medical GmbH	Behandlung von mikrobiellen infektionen mit diagnose durch biomarker d-lactat

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH559912A5 (de) *	1971-09-09	1975-03-14	Hoffmann La Roche
US3925183A (en) *	1972-06-16	1975-12-09	Energetics Science	Gas detecting and quantitative measuring device
CH585907A5 (de) *	1973-08-06	1977-03-15	Hoffmann La Roche
US4040908A (en) *	1976-03-12	1977-08-09	Children's Hospital Medical Center	Polarographic analysis of cholesterol and other macromolecular substances
DE2823485C2 (de) *	1978-05-30	1986-03-27	Albert Prof. Dr. 3550 Marburg Huch	Trogelektrode
US4225410A (en) *	1978-12-04	1980-09-30	Technicon Instruments Corporation	Integrated array of electrochemical sensors
US4169779A (en) *	1978-12-26	1979-10-02	Catalyst Research Corporation	Electrochemical cell for the detection of hydrogen sulfide
US4420564A (en) *	1980-11-21	1983-12-13	Fuji Electric Company, Ltd.	Blood sugar analyzer having fixed enzyme membrane sensor
AT369254B (de) *	1981-05-07	1982-12-27	Otto Dipl Ing Dr Tech Prohaska	Medizinische sonde
JPS6036949A (ja) *	1983-08-09	1985-02-26	Ngk Insulators Ltd	酸素センサ素子
SE8305704D0 (sv) *	1983-10-18	1983-10-18	Leo Ab	Cuvette
US4579643A (en) *	1983-11-18	1986-04-01	Ngk Insulators, Ltd.	Electrochemical device
US4938860A (en) *	1985-06-28	1990-07-03	Miles Inc.	Electrode for electrochemical sensors
US4935106A (en) *	1985-11-15	1990-06-19	Smithkline Diagnostics, Inc.	Ion selective/enzymatic electrode medical analyzer device and method of use
GB8612861D0 (en) *	1986-05-27	1986-07-02	Cambridge Life Sciences	Immobilised enzyme biosensors
JPS636451A (ja) *	1986-06-27	1988-01-12	Terumo Corp	酵素センサ
US4935346A (en) *	1986-08-13	1990-06-19	Lifescan, Inc.	Minimum procedure system for the determination of analytes
GB2201248B (en) *	1987-02-24	1991-04-17	Ici Plc	Enzyme electrode sensors
US4796014A (en) *	1987-03-24	1989-01-03	Chia Jack T	Device for detecting urine in diapers

1989
- 1989-03-13 US US07/322,598 patent/US5128015A/en not_active Expired - Lifetime
- 1989-03-14 AT AT89904316T patent/ATE157123T1/de not_active IP Right Cessation
- 1989-03-14 EP EP89904316A patent/EP0406304B1/de not_active Expired - Lifetime
- 1989-03-14 WO PCT/US1989/001057 patent/WO1989008713A1/en not_active Ceased
- 1989-03-14 DE DE68928266T patent/DE68928266T2/de not_active Expired - Lifetime
- 1989-10-16 KR KR1019890701897A patent/KR900700620A/ko not_active Withdrawn
1990
- 1990-09-13 NO NO904001A patent/NO301241B1/no not_active IP Right Cessation
- 1990-09-14 DK DK221090A patent/DK221090A/da not_active Application Discontinuation
- 1990-09-14 FI FI904534A patent/FI101021B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI904534A0 (fi)	1990-09-14
EP0406304A1 (de)	1991-01-09
DE68928266D1 (de)	1997-09-25
EP0406304B1 (de)	1997-08-20
HK1002833A1 (en)	1998-09-18
ATE157123T1 (de)	1997-09-15
NO904001D0 (no)	1990-09-13
WO1989008713A1 (en)	1989-09-21
US5128015A (en)	1992-07-07
FI101021B (fi)	1998-03-31
DK221090D0 (da)	1990-09-14
KR900700620A (ko)	1990-08-16
NO904001L (no)	1990-11-06
DK221090A (da)	1990-11-12
EP0406304A4 (en)	1991-01-30
DE68928266T2 (de)	1998-01-15

Legal Events

Date	Code	Title	Description
2009-03-30	MK1K	Patent expired

Publication	Publication Date	Title
NO301241B1 (no)	1997-09-29	Prövecelle, apparat og fremgangsmåte for bestemmelse av konsentrasjonen av en forbindelse i en vandig væskepröve
US5108564A (en)	1992-04-28	Method and apparatus for amperometric diagnostic analysis
USRE36268E (en)	1999-08-17	Method and apparatus for amperometric diagnostic analysis
US6413411B1 (en)	2002-07-02	Method and apparatus for amperometric diagnostic analysis
US6767441B1 (en)	2004-07-27	Biosensor with peroxidase enzyme
CA2224308C (en)	2008-05-06	Electrochemical biosensor test strip
JP3267936B2 (ja)	2002-03-25	バイオセンサ
US6051392A (en)	2000-04-18	Method for quantitating a substrate and measurement device used therefor
EP1181539B1 (de)	2015-04-08	Wegwerfbarer submikroliter-volumiger Sensor
US20100096276A1 (en)	2010-04-22	Multicomponent analysis sensor and method of measuring multiple components
JP2003114214A (ja)	2003-04-18	分析物濃度決定において使用するための方法および装置
KR20030036609A (ko)	2003-05-09	헤모글로빈 감지기
CA2359321A1 (en)	2000-08-03	Diagnostic test for the measurement of analyte in a biological fluid
KR20030014375A (ko)	2003-02-17	신속 반응형 포도당 센서
JPH11352094A (ja)	1999-12-24	電気化学分析素子
EP0794429A1 (de)	1997-09-10	Cholesterinsensor
JP2001330581A (ja)	2001-11-30	基質濃度定量法
JP3267933B2 (ja)	2002-03-25	基質の定量法
AU644059B2 (en)	1993-12-02	Method and apparatus for amperometric diagnostic analysis
JP3487410B2 (ja)	2004-01-19	バイオセンサ
CA1340516C (en)	1999-04-27	Method and apparatus for amperometric diagnostic analysis
JP2543057B2 (ja)	1996-10-16	バイオセンサの製造方法およびバイオセンサ用電極板の製造方法
HK1002833B (en)	1998-09-18	Method and apparatus for amperometric diagnostic analysis
Chen et al.	2009	Non-enzymatic disposable test strip for detecting uric acid in whole blood
EP1578985B1 (de)	2007-10-31	Lactate biodetektion strip